KFDA requires additional warning for OTC pain relievers

Published: 2010-07-19 06:56:00

Updated: 2010-07-19 06:56:00

The Korea Food and Drug Administration has recently issued an additional warning that requires manufacturers of OTC pain relievers and fever reducers to take preventive measures about potential safety risks associated with overdose of these popular drugs.

Products covered by the KFDA action in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK